Episode

Episode 206: biomarkers for dementia, toileting, bleeding risk, and diagnosing volume overload.

Podcast: Primary Care Update
Published: May 6, 2026
Duration seconds: 1821
Processing state: not_requested
Canonical source: https://podcasters.spotify.com/pod/show/primary-care-update/episodes/Episode-206-biomarkers-for-dementia--toileting--bleeding-risk--and-diagnosing-volume-overload-e3ivo12
Audio: https://anchor.fm/s/5693a5c/podcast/play/119578082/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-6%2Fc3910e69-70be-2e5a-2f84-55adeedfc2e7.mp3
JSON: /v1/public/podcasts/primary-care-update-1000928/episodes/episode-206-biomarkers-for-dementia-toileting-bleeding-risk-and-diagnosing-volume-overload
Markdown: /podcast/primary-care-update-1000928/episode-206-biomarkers-for-dementia-toileting-bleeding-risk-and-diagnosing-volume-overload.md

Actions

POST https://stenobird.com/v1/public/podcasts/primary-care-update-1000928/episodes/episode-206-biomarkers-for-dementia-toileting-bleeding-risk-and-diagnosing-volume-overload/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/primary-care-update-1000928/episode-206-biomarkers-for-dementia-toileting-bleeding-risk-and-diagnosing-volume-overload.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Join primary care faculty Gary Ferenchick, Kate Rowland, Henry Barry and Mark Ebell as they discuss 4 important new studies: the value (?) Of biomarkers in cognitive impairment, toilet training, bleeding risk with apixaban versus rivaroxaban for VTE, and diagnosing volume overload in adults from the JAMA Rational Clinical Exam series.